Advertisement

Organisation › Details
ARCH Venture (Group)
ARCH Venture Partners is one of the largest early stage technology venture firms in the U.S. ARCH has co-founded and provided initial investments for more than 250 companies organized around innovations from research universities, national laboratories, corporate research groups and entrepreneurs. By focusing on leading scientific innovators, ARCH has been at the forefront of investing in major areas of innovation in the life sciences and physical sciences, and has helped to catalyze revolutionary advances in genomics, nanotechnology, industrial biotechnology and major disease treatments. ARCH has raised ten primary funds with combined committed capital at the time raised of approximately $4.5 billion. *
![]() |
Start | 1986-01-01 established |
Today | ARCH Venture Partners | |
![]() |
Industry | venture capital |
![]() |
Person | Crandell, Keith (ARCH Venture Partners 201302 Managing Director + Co-founder) |
![]() |
Region | Chicago, IL |
Country | United States (USA) | |
Street | 8725 W. Higgins Road. Suite 290 | |
City | 60631 Chicago, IL | |
Tel | +1-773-380-6600 | |
Address record changed: 2022-04-17 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 2,500,000,000 (funds, managed 2017-03-16) | |
* Document for »About Section«: Vizgen. (1/30/20). "Press Release: Vizgen Launches with $14M Series A Financing Led by ARCH Venture Partners and Northpond Ventures". Cambridge, MA. | ||
Record changed: 2022-04-17 |
Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top